If you've been living with long COVID for a while, there's a decent chance you've also started reacting to things that never used to bother you. Wine gives you a pounding headache. Leftovers make your stomach churn. Your heart races after a shower that's just a little too hot. You haven’t brought it to the attention of your family or friends as you know they might not believe you. On paper, you even question your symptoms, because none of them sound connected.
I've spent a lot of time in the research literature on this exact overlap, and I want to walk you through what's actually known, what's still theory, and why so many long COVID patients are landing on the same two words: mast cells.
To be upfront, this article is meant to inform, not diagnose. Long COVID, histamine intolerance, and mast cell activation syndrome (MCAS) are all complex, still-evolving areas of medicine. Anyone with persistent or worsening symptoms should work with a physician, ideally one familiar with post-viral illness or allergy and immunology, rather than trying to self-diagnose from a blog post (including this one).
What's Actually Going On With Long COVID and Histamine Intolerance
Long COVID, also called post-acute sequelae of SARS-CoV-2 infection (PASC), refers to symptoms that persist for weeks or months after the initial infection has cleared. Researchers estimate it affects tens of millions of people worldwide, with fatigue, brain fog, shortness of breath, and a racing heart rate among the most commonly reported complaints [1][2].
What makes long COVID so frustrating, both for patients and for the clinicians trying to treat it, is that it doesn't behave like a single disease. It looks more like a cluster of overlapping conditions, involving immune dysregulation, lingering viral fragments, and autonomic nervous system disruption. But also, increasingly, the involvement of a very old and very reactive part of your immune system: the mast cell [1].
Meet the Mast Cell: Your Body's Alarm System Linking Long COVID and MCAS
Mast cells are immune cells that live in your skin, gut lining, airways, and around your blood vessels and nerves. Think of them as sentries stationed at every entry point into your body. When they detect a threat, real or perceived, they release a flood of chemical messengers. Histamine is the most famous among them, along with tryptase, cytokines, and other inflammatory compounds [3].
This is a good system when it's working correctly. It's how your body responds to a bee sting or fights off a pathogen. The trouble starts when mast cells become chronically hyperreactive, firing off at triggers that shouldn't warrant a response at all: certain foods, temperature changes, stress, exercise, even strong smells. When that happens repeatedly across multiple organ systems, clinicians may consider a diagnosis of mast cell activation syndrome. MCAS is a condition that was already being studied well before the pandemic but has gained renewed attention because of its apparent overlap with long COVID [3].
The Emerging Mast Cell, Long COVID MCAS Connection
This is where the research gets genuinely interesting, and where I want to be careful about language, because the science here is still emerging rather than settled.
Back in 2020, during the earliest wave of the pandemic, a group of physicians published a hypothesis paper proposing that undiagnosed MCAS might explain why some COVID-19 patients developed severe hyperinflammatory responses, and why some went on to develop lingering post-COVID symptoms [3]. It was a bold idea at the time. It was built largely on clinical observation and pattern recognition rather than hard data, but it planted a seed that a lot of subsequent research has since tried to test.
The following year, that same research group published a more formal study. It compared 136 long COVID patients, 136 healthy controls, and 80 patients with an established MCAS diagnosis. What they found was striking: people with long COVID reported mast cell activation symptoms, things like flushing, hives, gut upset, and rapid heart rate. What was most interesting is the severity level was nearly identical to that of the confirmed MCAS group, and significantly higher than controls [4]. That paper, published in the International Journal of Infectious Diseases, remains one of the most cited pieces of evidence for the long COVID MCAS connection.
Lab-based research has echoed this pattern. A 2022 study in the journal Allergy measured actual mast cell mediators, not just symptoms, in the blood of patients with post-acute COVID-19 syndrome. They found elevated levels of active tryptase and other mast cell derived proteins compared with people who had recovered from COVID-19 without lingering symptoms. It suggested a biological signature of mast cell activation rather than just a coincidence of overlapping complaints [5].
More recent reviews have expanded on this idea. A 2023 immunology review described an activated state of mast cells in long COVID patients. Results were marked by abnormal granulation and excessive release of inflammatory cytokines, and positioned mast cell dysfunction as one piece of a broader picture of immune dysregulation in long COVID, alongside T-cell depletion and chronic low-grade inflammation [1]. A more recent narrative review has gone further still, exploring how mast cells positioned near nerves and blood vessels may help explain some of the neuropathic pain, small fiber neuropathy, and autonomic symptoms reported in long COVID. The mechanism discussed suggested it was potentially through activation via the SARS-CoV-2 spike protein interacting with ACE2 and toll-like receptor 4 on the mast cell surface [2].
Where Long COVID and Histamine Intolerance Fit Into the Picture
So where does histamine intolerance come in, and how is it different from MCAS?
Histamine intolerance is generally understood as a problem with clearing histamine rather than over producing it. Under normal circumstances, an enzyme called diamine oxidase (DAO), found mainly in the gut lining, breaks down histamine that comes from food before it can build up and cause symptoms [6][7]. When DAO activity is reduced, whether from genetics, certain medications, gut inflammation, or other factors, histamine from meals can accumulate faster than the body clears it. Higher than tolerated histamine levels end up producing symptoms like headaches, flushing, hives, digestive discomfort, and a racing heart. Sound familiar? Exactly! Many of the same complaints associated with long COVID [6][8].
Research has shown that people with confirmed histamine intolerance tend to have measurably lower serum DAO activity than healthy controls. Additionally, symptoms often improve on a low-histamine diet or with DAO supplementation, which supports the idea that this is a real, measurable physiological difference rather than just a food sensitivity story [8][9].
If mast cells in long COVID are chronically activated and releasing extra histamine into the system, as some of the research above suggests may be happening, it's not hard to see how that could overwhelm even a normally functioning DAO enzyme. Or it may compound the effects of an already-reduced DAO capacity. This is the theoretical bridge that a growing number of researchers and clinicians are exploring: not that long COVID causes histamine intolerance in a strict clinical sense, but that mast cell-driven histamine release may produce a functionally similar experience, sometimes described informally as "long COVID histamine intolerance," even in people who never had food-related histamine issues before getting sick.
Why the Symptom Overlap Is So Confusing when it comes to Long COVID and Histamine Intolerance
Part of what makes this topic so hard to untangle, for patients and doctors alike, is that long COVID, MCAS, and histamine intolerance share a strikingly similar symptom list. Fatigue that doesn't improve with rest. Brain fog. A heart rate that spikes when you stand up too fast, sometimes diagnosed as postural orthostatic tachycardia syndrome (POTS). Digestive symptoms that flare after certain meals. Flushing or hives with no obvious allergic trigger. Sleep that never feels restorative.
None of these symptoms are unique to mast cell involvement on their own, which is exactly why they're so easy to dismiss or misattribute. But researchers studying long COVID have pointed out that mast cells sit at a useful intersection: they're wired into the autonomic nervous system, the gut lining, and the vascular system all at once. It means a single overactive mast cell population could plausibly contribute to symptoms across several of these categories simultaneously, rather than requiring several unrelated explanations [1][2]. That's part of why the mast cell hypothesis has generated so much interest, even while remaining unproven as a universal explanation.
It's also worth noting that histamine itself plays a role in regulating blood vessel tone and heart rate, so a state of excess histamine circulating in the body could plausibly contribute to the racing heart and lightheadedness that so many long COVID and POTS patients describe, independent of any formal MCAS diagnosis [3][5].
An Honest Look at the Uncertainty in Long COVID and Histamine Intolerance
I think it's important to slow down here, because not every study agrees. And good science reporting means showing you the disagreement rather than just the tidy narrative.
A 2024 case-control study specifically looking for mast cell involvement in long COVID patients did not find clear evidence of mast cell activation using their chosen biomarkers. The authors concluded that mast cells might not be a universal driver of long COVID symptoms in every patient [10]. This doesn't cancel out the other findings. But it's a useful reminder that long COVID is likely not one condition with one mechanism. Mast cell and histamine involvement may be relevant for a meaningful subset of patients, particularly those with prominent flushing, gut symptoms, or postural heart rate changes. Other patients' symptoms may be driven by entirely different processes, like viral persistence, autoimmunity, or vascular dysfunction.
Long COVID and Histamine Intolerance: Emerging Research About Management
Because this research is still developing, treatment approaches remain investigational rather than standardized. Each case should be discussed with a healthcare provider rather than attempted independently.
That said, a small 2023 pilot study offers a glimpse of where this research may be heading. Researchers treated long COVID patients whose symptoms were attributed to mast cell activation with a combination of an H1 blocker (fexofenadine) and an H2 blocker (famotidine). After twenty days, treated patients showed improvement in fatigue, brain fog, abdominal symptoms, and elevated heart rate compared with untreated patients [11]. It's a small study and far from definitive proof, but it lines up with the broader hypothesis and gives clinicians a testable, relatively low-risk avenue to explore with appropriate patients.
Separately, in the histamine intolerance literature, DAO enzyme supplementation and low-histamine dietary approaches have shown symptom improvement in controlled pilot studies among people with confirmed histamine intolerance. It offers another angle some clinicians are borrowing from when working with long COVID patients who report histamine-type reactivity [9].
The Takeaway
Emerging research suggests a plausible, and in some studies measurable, connection between long COVID and MCAS driven by mast cell hyperactivity, with histamine as one of the key chemical messengers involved. For some people living with long COVID, symptoms that seem random, food reactions, flushing, racing heart, gut upset, may share a common thread running back to overactive mast cells and the histamine they release.
This isn't a settled diagnosis you can self-apply from home. And it isn't the whole story for everyone with long COVID. But if these patterns sound familiar, it may be worth raising the topic of MCAS and histamine intolerance with your doctor, ideally an allergist, immunologist, or long COVID specialist who is following this research closely. The science is moving quickly, and patients who bring good questions to that conversation tend to get further, faster.
References
- Sumantri S, Rengganis I. Immunological dysfunction and mast cell activation syndrome in long COVID. Asia Pac Allergy. 2023 Mar;13(1):50-53.
- Morcos ZL, Theoharides TC. Long COVID neuropathy: The role of mast cells. J Neuropathol Exp Neurol. 2026 May 1;85(5):413-424.
- Afrin LB, Weinstock LB, Molderings GJ. Covid-19 hyperinflammation and post-Covid-19 illness may be rooted in mast cell activation syndrome. Int J Infect Dis. 2020 Nov;100:327-332.
- Weinstock LB, Brook JB, Walters AS, Goris A, Afrin LB, Molderings GJ. Mast cell activation symptoms are prevalent in Long-COVID. Int J Infect Dis. 2021 Nov;112:217-226.
- Wechsler JB, Butuci M, Wong A, Kamboj AP, Youngblood BA. Mast cell activation is associated with post-acute COVID-19 syndrome. Allergy. 2022 Apr;77(4):1288-1291.
- Maintz L, Novak N. Histamine and histamine intolerance. Am J Clin Nutr. 2007 May;85(5):1185-96.
- Arih K, Đorđević N, Košnik M, Rijavec M. Evaluation of Serum Diamine Oxidase as a Diagnostic Test for Histamine Intolerance. Nutrients. 2023 Oct 2;15(19):4246.
- Manzotti G, Breda D, Di Gioacchino M, Burastero SE. Serum diamine oxidase activity in patients with histamine intolerance. Int J Immunopathol Pharmacol. 2016 Mar;29(1):105-11.
- Schnedl WJ, Schenk M, Lackner S, Enko D, Mangge H, Forster F. Diamine oxidase supplementation improves symptoms in patients with histamine intolerance. Food Sci Biotechnol. 2019 May 24;28(6):1779-1784.
- Lenning OB, Jonsson G, Grimstad T, Janssen EAM, Braut GS, Berven F, Omdal R. No signs of mast cell involvement in long-COVID: A case-control study. Scand J Immunol. 2024 Nov;100(5):e13407.
- Salvucci F, Codella R, Coppola A, Zacchei I, Grassi G, Anti ML, Nitisoara N, Luzi L, Gazzaruso C. Antihistamines improve cardiovascular manifestations and other symptoms of long-COVID attributed to mast cell activation. Front Cardiovasc Med. 2023 Jul 17;10:1202696.
Anita Tee
My name is Anita Tee. I'm a nutritional scientist specializing in histamine intolerance. I hold a Master of Science in Personalized Nutrition and a Bachelor of Science in Human Biology and Psychology.
For the past ten years, I have used my experience in nutritional and medical health sciences to create a scientifically backed, natural approach to healthcare that relies 100% on evidence-based research.
As I previously suffered from - and overcame - histamine intolerance, my focus is to increase recognition and expand the available resources and protocols for resolving the disorder. To date, I have helped over 4,000 individuals fully resolve or better manage their histamine intolerance symptoms.
